According to FDA prescribing information, injection site reactions vary by dose and formulation, with clinical trials showing rates of approximately 1.7-5.2% for Mounjaro and 2.4-5.3% for Zepbound, depending on the dose used
The consultation also serves as a time for patient education, where you can ask questions and gain a deeper understanding of peptide therapy
Nausea: 246% increased risk , Vomiting 325% increased risk , Diarrhea 137% increased risk , and Drug discontinuation due to these adverse events :161% increased risk
Of note, inactivation of the genes encoding DIOs in rodent models has revealed a role for DIO type 1 in iodine homeostasis and the importance of DIOs type 2 and 3 in the maturation of auditory and visual systems during fetal development (10)
Protein quality matters alongside quantity
When combined with progestin therapy a central treatment for endometrial hyperplasia and a common therapy for endometriosis the response was stronger than with progestin alone